MicroRNAs as new player in rheumatoid arthritis.

MicroRNAs (miRNAs) are small noncoding RNA molecules that negatively regulate gene expression at the post-transcriptional level. Currently, there are 939 mature human miRNA sequences listed in the Sanger updated miRNA registry. There are approximately 1500 predicted miRNAs in the human genome that may regulate the expression of one third of our genes. By controlling the accumulation of the target protein(s) in cells, these regulatory RNA molecules participate in key functions in many physiological networks and their deregulation has been implicated in the pathogenesis of serious human disorders, such as cancer and infection. The implication of miRNAs in immune-mediated disorders such as rheumatoid arthritis (RA) has recently emerged suggesting that miRNA-based therapeutic approaches may have a promising potential in these diseases. Here, we provide an overview of the state-of-the-art on miRNAs in RA, focusing on both systemic and local features of the pathology.

[1]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[2]  Daniel G Tenen,et al.  Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. , 2010, Blood.

[3]  N. Rajewsky,et al.  Regulation of the Germinal Center Response by MicroRNA-155 , 2007, Science.

[4]  Hana Lee,et al.  Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. , 2009, Immunity.

[5]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[6]  Takashi Nakamura,et al.  Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis , 2010, Arthritis research & therapy.

[7]  K. Schulze-Osthoff,et al.  IκBζ expression is regulated by miR-124a , 2009 .

[8]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[9]  S. Miyaki,et al.  Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a. , 2009, Arthritis and rheumatism.

[10]  H. Horlings,et al.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.

[11]  Susan R. Quinn,et al.  IL-10 Inhibits miR-155 Induction by Toll-like Receptors* , 2010, The Journal of Biological Chemistry.

[12]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[13]  H. Lassmann,et al.  MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. , 2009, Brain : a journal of neurology.

[14]  J. Yue,et al.  Conservation of miR-15a/16-1 and miR-15b/16-2 clusters , 2010, Mammalian Genome.

[15]  A. Pivarcsi,et al.  MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. , 2008, Seminars in cancer biology.

[16]  B. Kaczkowski,et al.  MicroRNAs and potential target interactions in psoriasis. , 2010, Journal of dermatological science.

[17]  J. A. Lozano,et al.  Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients , 2009, PloS one.

[18]  J. L. Hansen,et al.  MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes. , 2010, Experimental cell research.

[19]  C. McCall,et al.  MicroRNAs Distinguish Translational from Transcriptional Silencing during Endotoxin Tolerance* , 2010, The Journal of Biological Chemistry.

[20]  Gordon J. Lithgow,et al.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8 , 2009, Aging.

[21]  J. Berman,et al.  MicroRNAs are expressed and processed by human primary macrophages. , 2010, Cellular immunology.

[22]  Masahiro Kurosaka,et al.  MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[23]  L. O’Neill.  Boosting the brain's ability to block inflammation via microRNA-132. , 2009, Immunity.

[24]  G. Macino,et al.  miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. , 2010, Human immunology.

[25]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[26]  Francesca Meloni,et al.  An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. , 2010, Blood.

[27]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[28]  Igor M. Dozmorov,et al.  Identification of Unique MicroRNA Signature Associated with Lupus Nephritis , 2010, PloS one.

[29]  J. Michálek,et al.  microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. , 2010, Cellular immunology.

[30]  P. Janson,et al.  MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis? , 2007, PloS one.

[31]  Yuzhang Wu,et al.  Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis , 2010, Arthritis research & therapy.

[32]  Michael T. McManus,et al.  Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity , 2008, The Journal of experimental medicine.

[33]  Mark M. Davis,et al.  miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.

[34]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[35]  F. Jiao,et al.  miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells. , 2010, Oncology reports.

[36]  H. Lodish,et al.  MicroRNA-125b is a novel negative regulator of p53. , 2009, Genes & development.

[37]  H. Strobl,et al.  miR-146a Is Differentially Expressed by Myeloid Dendritic Cell Subsets and Desensitizes Cells to TLR2-Dependent Activation , 2010, The Journal of Immunology.

[38]  N. Baroukh,et al.  Function of microRNA‐375 and microRNA‐124a in pancreas and brain , 2009, The FEBS journal.

[39]  G. Glinsky.  SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways , 2008, Cell cycle.

[40]  E. Chan,et al.  Clinical and serological features of patients with autoantibodies to GW/P bodies. , 2007, Clinical immunology.

[41]  Wei Zhou,et al.  miR‐146a in PBMCs modulates Th1 function in patients with acute coronary syndrome , 2010, Immunology and cell biology.

[42]  Frances Gotch,et al.  miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator , 2010, Nature Cell Biology.

[43]  George A Calin,et al.  MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. , 2009, Cancer research.

[44]  G. Marti,et al.  Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity , 2009, Molecular Cancer Therapeutics.

[45]  Thomas Tuschl,et al.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.

[46]  Kaleb M. Pauley,et al.  Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients , 2008, Arthritis research & therapy.

[47]  A. Rudensky,et al.  Dicer-dependent microRNA pathway safeguards regulatory T cell function , 2008, The Journal of experimental medicine.

[48]  Li-Na Wei,et al.  MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. , 2009, The Biochemical journal.

[49]  Keiichiro Nishida,et al.  Expression of microRNA-146 in rheumatoid arthritis synovial tissue. , 2008, Arthritis and rheumatism.

[50]  Michael Detmar,et al.  Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[51]  S. Pfeffer,et al.  Bruton’s Tyrosine Kinase Is Involved in miR-346-Related Regulation of IL-18 Release by Lipopolysaccharide-Activated Rheumatoid Fibroblast-Like Synoviocytes 1 , 2009, The Journal of Immunology.

[52]  Z. Xu,et al.  Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients , 2007, Lupus.

[53]  C. Croce,et al.  miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Iliopoulos,et al.  The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. , 2009, Immunity.

[55]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[56]  Jia-feng Wang,et al.  Serum miR-146a and miR-223 as potential new biomarkers for sepsis. , 2010, Biochemical and biophysical research communications.

[57]  Pin Wang,et al.  MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK21 , 2009, The Journal of Immunology.

[58]  S. Cook,et al.  MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. , 2010, Cardiovascular research.

[59]  Lianbo Yu,et al.  Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.

[60]  Xiang-Dong Fu,et al.  Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. , 2009, BMB reports.